World of DTC Marketing

MARCH 24, 2022

I’ve seen some new energy and thinking taking root in some big pharma companies. Still, I’m also seeing some recycled executives show up at other companies when they should have been removed permanently from the industry. John worked for a division of a major pharma company in Cambridge.

Pharma Companies 213

Pharma Companies HR Sales Regulation 213

Find Me Cure

SEPTEMBER 2, 2020

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97

Pharmaceutical Technology

DECEMBER 21, 2022

But as the field grows in leaps and bounds, many authorities have prioritised the release of new guidelines, frameworks, and regulations to keep pace with these advances. According to a cross-sectorial survey by the consulting firm Mckinsey & Company , 52% of respondents reported investing in AI this year compared to 40% in 2018.

Regulation 351

Regulation Pharma Companies Medicine Clinical Trials 351

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

pharmaphorum

AUGUST 21, 2020

Pfizer and BioNTech have said their COVID-19 vaccine could be ready for regulators to review by October and approved by the end of the year after releasing more favourable data from an early-stage trial. Could AI prevent future pandemics by developing an armoury of drugs that work against all coronaviruses?

Vaccination 105

Vaccination Vaccine Regulation Manufacturing 105

pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 99

Drugs Pharma Companies Licensing Licensing 99

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. That leaves three years for pharma companies to prepare. asked panel chair Ipsita Smolinski, MD of consultancy Capitol Street. It’s much needed. It’s a hot area.”

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

pharmaphorum

JULY 8, 2022

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. DCTs have been around for many years, long before the pandemic, but now companies have had the opportunity to utilise DCT approaches,” John Reites, CEO of Thread, told pharmaphorum.

Clinical Trials 88

Clinical Trials Clinical Trials Trials Regulation 88

pharmaphorum

FEBRUARY 14, 2022

According to Deloitte, this can be attributed to the increase in the number of assets in the late stage pipeline of the companies studied, which saw an average of 16.1 assets per company in later stages of development.

Production 98

Production Clinical Trials Clinical Trials Sales 98

pharmaphorum

MAY 25, 2022

The move to online international meetings has left pharma companies with uncertainty around contact compliance. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.

Regulation 105

Regulation Compliance Manufacturing Medicine 105

pharmaphorum

APRIL 30, 2021

Savana’s Dr Ignacio Medrano explains how natural language processing technology is opening up huge amounts of previously-inaccessible real-world evidence for pharma and regulators. Research predicts the post-COVID landscape for HCP engagement. How to improve payer engagement with tailored value communication.

Marketing 94

Marketing Sales Regulation Drugs 94

World of DTC Marketing

MARCH 26, 2021

Pharma cannot afford to let good people leave without so much as an exit interview to try and retain them. A colleague recently decided to leave her organization to join another pharma company. To me, it’s the continuing loss of talented people who understand how to work in a regulated industry and excel.

Pharma Companies 156

Pharma Companies Production Regulation Vaccination 156

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Linking pharma with patients.

Clinical Trials 91

Clinical Trials Clinical Trials Trials Clinical Research 91

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

pharmaphorum

OCTOBER 28, 2020

Claus Møldrup explores research showing that patients want their voice to be heard more by pharma, and asks what a truly effective feedback loop for medicines might look like. Pharma remains stubbornly closed to feedback, with potentially damaging consequences for the industry, healthcare systems and patients. “As The way back.

Medicine 119

Medicine Pharma Companies Vaccination Vaccine 119

pharmaphorum

JANUARY 24, 2022

Protas will design and run smart clinical trials through collaborations with charities, foundations, academic research teams and industry partners, and will take on both repurposed and experimental drugs. “It’s not about making money from the trials, it’s about driving public health benefit,” he told the BBC.

Trials 92

Trials Drugs Clinical Trials Clinical Trials 92

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Pharma is a highly regulated industry and that is often why it is slow to adopt new technologies,” says Kazuki.

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

JUNE 16, 2022

There are already more than 30 DiGAs that have approved for use by the BfArM medical regulator and are covered by the national GKV health insurance system.

Hormones 95

Hormones Pharma Companies Regulation Drugs 95

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. AI algorithms are able to quickly analyse and spot patterns in vast swathes of data.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

JULY 5, 2021

billion to claim ownership of the contract research organisation. The handover comes four years after Pamplona Capital Management bought the company for around $5 billion, and just a few weeks after lab tech company Thermo Fisher Scientific agreed to acquire another CRO – PPD – in a deal valued at $17.4

Clinical Trials 64

Clinical Trials Clinical Trials Regulation Trials 64

pharmaphorum

MAY 27, 2022

Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. There is a huge opportunity for pharma companies to capitalise on by focusing on increased DEI in clinical trials.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

NOVEMBER 11, 2022

IQVIA’s research has been helped by a “dramatic increase” in diversity data collection in phase 2 and 3 trials in the past six years, which has provided a baseline against which progress can be gauged. Overall, inclusion of both groups falls well short of the 2020 US demographic level of 13.6% for Hispanics.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Pharma Companies 90

Drug Discovery World

FEBRUARY 6, 2024

Technologies like artificial intelligence (AI), machine learning (ML) and robotics/automation are enabling researchers to process enormous data sets and conduct preclinical investigations in record time, speeding up the process and offering greater accuracy. Universities are also using these digital technologies to advance their research.

Marketing 69

Marketing Medicine Genome Genomics 69

pharmaphorum

DECEMBER 9, 2022

The PharmaStars accelerator was set up last year to help bridge the gap between digital health start-ups and potential pharma partners, which can be instrumental in making sure their technologies meet their potential – and help them to navigate the challenges of developing them in the highly regulated healthcare environment.

Life Science 52

Life Science DNA Genome Genomics 52

XTalks

MARCH 28, 2024

Bettica said the company’s focus is to now “make Duvyzat available as a treatment for DMD management in the US as quickly as possible.” In November, the FDA extended its decision deadline by three months to allow extra time for regulators to review additional information submitted by Italfarmaco as part of a new drug application.

FDA Approval 105

FDA Approval Genetics Gene Therapy Gene 105

pharmaphorum

NOVEMBER 5, 2020

million) in funding that will be used to develop an artificial intelligence (AI) data platform that can be used by pharma companies to gain insights into how patients perceive them. Talking Medicines has raised £1.1 million ($1.4

Medicine 59

Medicine Pharma Companies Branding Regulation 59

Drug Discovery World

MAY 6, 2024

In a boost to cancer research for both regions, in November 2023, Cancer Research UK and the KWF Dutch Cancer Society (KWF) announced a multi-project strategic partnership. Beyond this specific plan, France has a strong policy to support innovation with research tax credits and specific programmes.

Drugs 59

Drugs Life Science Gene Editing Gene 59

pharmaphorum

NOVEMBER 4, 2020

Since then the story of Alzheimer’s research has been one of expensive failures as experimental drugs, mainly targeting the amyloid plaques found in the brains of people with the disease, failed to stop or slow cognitive decline in clinical trials.

Trials 69

Trials Drugs Bacteria Pharma Companies 69

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. About the interviewee.

Marketing 105

Marketing Drugs Regulation Development 105

Creogenic Pharma

FEBRUARY 17, 2021

Consequently, if you still have all the marketing and operational abilities, but do not possess enough funds, you may watch out for a pharma franchise at an India firm that offers to establish the installation branches. Growth of PCD Pharma Franchise.

Pharma Companies 52

Pharma Companies Production Manufacturing Marketing 52

Drug Discovery World

DECEMBER 27, 2023

Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. Listen here. This episode is available here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

pharmaphorum

APRIL 28, 2022

Despite the inherent difficulties, major pharma companies do take aim at rare diseases, usually with dedicated units focusing on clusters of rare diseases that afflict the same part of the body. How big pharma tackles rare diseases. It’s a different business model, if you will,” Miquel said. “So So that is the trick.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

pharmaphorum

JANUARY 29, 2021

California-based Sangamo Therapeutics is one such company that believes in the powerful potential of in vivo genome editing and regulation, together known as genome engineering, and has built up a sizable preclinical pipeline of genome regulation treatments for diseases such as Huntington’s disease and Amyotrophic lateral sclerosis (ALS).

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

MAY 20, 2022

Last year, the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services , an initiative that works with pharma companies on clinical trial recruitment and even hosts trial sites at certain retail locations. Why is that now important for clinical research? JR: Let’s flip it.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Clinical Research 90

pharmaphorum

NOVEMBER 23, 2020

Pharma companies, healthcare providers and governments share a well-established common purpose: the desire to make disease a thing of the past. I saw a statistic in a Health Europe article, published in September this year, which reported that 81% of patients do not feel listened to by pharma companies.

Pharma Companies 128

Pharma Companies Regulation Development Compliance 128

pharmaphorum

MAY 14, 2021

Long headquartered in London, the EU drug regulator is now severed from the country both physically and systematically, with its base now in Amsterdam and the UK now assessing drugs through its own regulatory agency, MHRA. It’s important to remember that the UK market represents only 2.5%

Marketing 59

Marketing Regulation Medicine Life Science 59

pharmaphorum

OCTOBER 7, 2021

Rewind to March of 2020, and pharma companies were facing a communication crisis. Thankfully, many pharma companies had already started on a journey towards digital engagement, and healthcare professionals (HCPs) are embracing the medium more than ever before, thanks in part to newer generations who are increasingly digitally-savvy.

Pharma Companies 97

Pharma Companies Production Clinical Trials Clinical Trials 97